Restricted accessResearch articleFirst published online 2020-2
Association between tumor necrosis factor-alpha gene rs1800629 ( - 308G/A) and rs361525 ( - 238G > A) polymorphisms and prostate cancer risk in an Iranian cohort
Prostate cancer (PCa) as the first men’s common cancer in the world and the third cancer in Iranian men is a heterogeneous disorder which sometimes several biopsies are needed for its diagnosis.
OBJECTIVES:
The aim of current study is finding new biomarkers in order to diagnose of PCa at the earliest possible stage. Hence, the relationship between rs1800629 and rs361525 polymorphisms of TNF- gene with PCa was investigated.
MATERIALS AND METHODS:
Blood DNA samples were collected from 100 patients with PCa, 110 with BPH, and 110 controls. Collected samples were examined using PCR-RFLP and Tetra-ARMS-PCR techniques to detect the desired polymorphisms.
RESULTS:
The frequency of rs1800629 genotypes in smokers was significantly different from non-smokers with PCa ( 0.001). Logistic regression analysis results showed that GA heterozygotes in comparison to GG homozygotes had higher risk of developing Benign Prostatic Hyperplasia (BPH) or prostate cancer. However, no significant correlation was considered between the risk of PCa and the TNF- gene polymorphisms (rs1800629 and rs361525).
CONCLUSIONS:
Although, the achieved results of this investigation demonstrated that the two examined genetic variants do not seem to be suitable markers for early diagnosis of prostate cancer in this pilot study; however increased risk for the disease is shown in GA heterozygotes and smokers which is indicative of some epigenetic factors influence on prostate cancer etiology.
BhavsarA. and VermaS., Anatomic imaging of the prostate, BioMed Research International2014 (2014).
2.
AaronL.FrancoO.E. and HaywardS.W., Review of prostate anatomy and embryology and the etiology of Benign Prostatic Hyperplasia, Urologic Clinics43 (2016), 279–288.
3.
HabibiM.MirfakhraieR.KhaniM.RakhshanA.AzargashbE. and PouresmaeiliF., Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: a case-control study, Gene634 (2017), 47–52.
4.
TaheriM.PouresmaeiliF.OmraniM.D.HabibiM.SarrafzadehS.NorooziR.RakhshanA.SayadA. and Ghafouri-FardS., Association of ANRIL gene polymorphisms with prostate cancer and Benign Prostatic Hyperplasia in an Iranian population, Biomarkers in Medicine11 (2017), 413–422.
5.
PernarC.H.EbotE.M.WilsonK.M. and MucciL.A., The epidemiology of prostate cancer, Cold Spring Harbor Perspectives in Medicine8 (2018), a030361.
6.
Sadeghi-GandomaniH.YousefiM.RahimiS.YousefiS.Karimi-RozvehA.HosseiniS.MahabadiA.AbarquiH.BorujeniN. and SalehiniyaH., The incidence, risk factors, and knowledge about the prostate cancer through worldwide and Iran, World Cancer Research Journal4 (2017), 1–8.
7.
KaranD.ThrasherJ. and LubaroffD., Prostate cancer: genes, environment, immunity and the use of immunotherapy, Prostate Cancer and Prostatic Diseases11 (2008), 230.
8.
WolfA.HoffmanR.VolkR. and PensonD., Prostate-specific antigen screening for prostate cancer: yes, no, or maybe? The Medical Roundtable General Medicine Edition (2019).
GopinathN., Tumor detection in prostate organ using canny edge detection technique, International Journal of Pure and Applied Mathematics118 (2018), 211–217.
11.
MansouriF., The role of the clinical and molecular assays in prostate cancer detection, Asian Journal of Pharmaceutical and Clinical Research10 (2017), 11–15.
12.
ChenN. and ZhouQ., The evolving Gleason grading system, Chinese Journal of Cancer Research28 (2016), 58.
13.
TosoianJ.J. and AntonarakisE.S., Molecular heterogeneity of localized prostate cancer: more different than alike, Translational Cancer Research6 (2017), S47.
14.
KgatleM.M.KallaA.A.IslamM.M.SathekgeM. and MooradR., Prostate cancer: epigenetic alterations, risk factors, and therapy, Prostate Cancer2016 (2016).
15.
MaL.ZhaoJ.LiT.HeY.WangJ.XieL.QinX. and LiS., Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis, Diagnostic Pathology9 (2014), 74.
16.
SchillaciO.ScimecaM.TrivignoD.ChiaravallotiA.FacchettiS.AnemonaL.BonfiglioR.SanteusanioG.TancrediV. and BonannoE., Prostate cancer and inflammation: a new molecular imaging challenge in the era of personalized medicine, Nuclear Medicine and Biology (2019).
17.
El-TahanR.R.GhoneimA.M. and El-MashadN., TNF-α gene polymorphisms and expression, Springerplus5 (2016), 1508.
18.
AggarwalB.B.GuptaS.C. and KimJ.H., Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey, Blood119 (2012), 651–665.
19.
BandilK.SinghalP.SharmaU.HussainS.BasuS.ParashariA.SinghV.SehgalA.ShivamA. and AhujaP., Impacts of TNF-LTA SNPs/haplotypes and lifestyle factors on oral carcinoma in an indian population, Molecular Diagnosis & Therapy20 (2016), 469–480.
20.
KohaarI.TiwariP.KumarR.NasareV.ThakurN.DasB.C. and BharadwajM., Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population, Breast Cancer Research and Treatment114 (2009), 347.
21.
KorobeinikovaE.MyrzaliyevaD.UgenskieneR.RaulinaityteD.GedminaiteJ.SmigelskasK. and JuozaityteE., The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients, BMC Genetics16 (2015), 70.
22.
KirkpatrickA.BidwellJ.Van den BruleA.MeijerC.PawadeJ. and GlewS., TNFα polymorphism frequencies in HPV-associated cervical dysplasia, Gynecologic Oncology92 (2004), 675–679.
23.
MotawiT.K.El-MaraghyS.A.SharafS.A. and SaidS.E., Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis, Journal of Advanced Research15 (2019), 103–110.
24.
HeidariZ.MoudiB.SaghebH.M. and MoudiM., Association of TNF-α gene polymorphisms with production of protein and susceptibility to chronic hepatitis B infection in the south east Iranian population, Hepatitis Monthly16 (2016).
25.
BandilK.SinghalP.DograA.RawalS.K.DovalD.VarshneyA.K. and BharadwajM., Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population, Inflammation Research66 (2017), 1085–1097.
26.
StephensK.E.LevineJ.D.AouizeratB.E.PaulS.M.AbramsG.ConleyY.P. and MiaskowskiC., Associations between genetic and epigenetic variations in cytokine genes and mild persistent breast pain in women following breast cancer surgery, Cytokine99 (2017), 203–213.
27.
ZhangX.WangJ.ShaoH. and ZhuW., Function of tumor necrosis factor alpha before and after mutation in gastric cancer, Saudi Journal of Biological Sciences24 (2017), 1920–1924.
28.
EatonK.D.RomineP.E.GoodmanG.E.ThornquistM.D.BarnettM.J. and PetersdorfE.W., Inflammatory gene polymorphisms in lung cancer susceptibility, Journal of Thoracic Oncology13 (2018), 649–659.
29.
WinchesterD.A.TillC.GoodmanP.J.TangenC.M.SantellaR.M.Johnson-PaisT.L.LeachR.J.XuJ.ZhengS.L. and ThompsonI.M., Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the prostate cancer prevention trial, The Prostate77 (2017), 908–919.
30.
DuG.-H.WangJ.-K.RichardsJ.R. and WangJ.-J., Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer, International Immunopharmacology66 (2019), 154–161.
31.
WeiB.F.FengZ.WeiW. and ChenX., Associations of TNF-α-238A/G and IL-10-1082G/A genetic polymorphisms with the risk of NONFH in the Chinese population, Journal of Cellular Biochemistry118 (2017), 4872–4880.
32.
DabhiB. and MistryK.N., In silico analysis of single nucleotide polymorphism (SNP) in human TNF-α gene, Meta Gene2 (2014), 586–595.
33.
SadjadiA.NooraieM.GhorbaniA.AlimohammadianM.ZahediM.-J.Darvish-MoghadamS.FakheriH.BabaiM.SemnaniS. and Mansour-GhanaeiF., The incidence of prostate cancer in Iran: results of a population-based cancer registry, Archives of Iranian Medicine10 (2007), 481–485.
34.
ÖzhanG.YanarH.T.ErtekinC. and AlpertungaB., Polymorphisms in tumour necrosis factor alpha (TNF) gene in patients with acute pancreatitis, Mediators of Inflammation2010 (2010).
35.
SolhjooS.Mahmoudzadeh SaghebH.HeidariZ.HashemiM. and Rigi LadezM., Association between TNF-α (-308G > A) gene polymorphism and chronic periodontitis, Zahedan Journal of Research in Medical Sciences16 (2014), 10–14.
36.
MalikS.S.BatoolR.MasoodN. and YasminA., Risk factors for prostate cancer: a multifactorial case-control study, Current Problems in Cancer42 (2018), 337–343.
37.
KimY.H.ByunY.J.KimW.T.JeongP.YanC.KangH.W.KimY.J.LeeS.C.MoonS.K.ChoiY.H.YunS.J. and KimW.J., CDC6 mRNA expression is associated with the aggressiveness of prostate cancer, J Korean Med Sci33 (2018), e303.
38.
LiangG.WangQ.JiangY.WumanerA. and WangQ., Lack of association between TNFα rs1800629 polymorphism and prostate cancer risk: a meta-analysis, Int J Clin Exp Med9 (2016), 9373–9380.
39.
XingB.LiX.K.ZhangS.F.LuQ.B.DuJ.ZhangP.H.YangZ.D.CuiN.GuoC.T.CaoW.C.ZhangX.A. and LiuW., Polymorphisms and haplotypes in the promoter of the TNF-alpha gene are associated with disease severity of severe fever with thrombocytopenia syndrome in Chinese Han population, PLoS Negl Trop Dis12 (2018), e0006547.
40.
Sáenz-LópezP.CarreteroR.CózarJ.M.RomeroJ.M.CantonJ.VilchezJ.R.TalladaM.GarridoF. and Ruiz-CabelloF., Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer, BMC Cancer8 (2008), 382.
41.
JangW.H.YangY.I.YeaS.S.LeeY.J.ChunJ.H.KimH.I.KimM.S. and PaikK.H., The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers, Cancer Lett166 (2001), 41–46.
42.
BerhaneN.SobtiR.C.MelesseS.MahdiS.A. and KassuA., Significance of tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer, Molecular Biology Reports39 (2012), 11125–11130.
43.
ZabaletaJ.LinH.-Y.SierraR.A.HallM.C.ClarkP.E.SartorO.A.HuJ.J. and OchoaA.C., Interactions of cytokine gene polymorphisms in prostate cancer risk, Carcinogenesis29 (2008), 573–578.
44.
KesarwaniP.MandhaniA. and MittalR.D., Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort, The Journal of Urology182 (2009), 2938–2943.
45.
DanforthK.N.RodriguezC.HayesR.B.SakodaL.C.HuangW.Y.YuK.CalleE.E.JacobsE.J.ChenB.E. and AndrioleG.L., TNF polymorphisms and prostate cancer risk, The Prostate68 (2008), 400–407.
46.
PachecoS.PachecoF.ZapataG.GarciaJ.PrevialeC.CuraH. and CraigW., Food habits, lifestyle factors, and risk of prostate cancer in Central Argentina: a case control study involving self-motivated health behavior modifications after diagnosis, Nutrients8 (2016), 419.
47.
JoshiM.VermaY.GautamA.ParmarG.LakkadB. and KumarS., Cytogenetic alterations in buccal mucosa cells of chewers of areca nut and tobacco, Archives of Oral Biology56 (2011), 63–67.
48.
MianM.F.LauzonN.M.StämpfliM.R.MossmanK.L. and AshkarA.A., Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke, Journal of Leukocyte Biology83 (2008), 774–784.
49.
LambertC.McCueJ.PortasM.OuyangY.LiJ.RosanoT.G.LazisA. and FreedB.M., Acrolein in cigarette smoke inhibits T-cell responses, Journal of Allergy and Clinical Immunology116 (2005), 916–922.
50.
HaddyN.SassC.MaumusS.MarieB.DroeschS.SiestG.LambertD. and VisvikisS., Biological variations, genetic polymorphisms and familial resemblance of TNF-α and IL-6 concentrations: STANISLAS cohort, European Journal of Human Genetics13 (2005), 109.
51.
ZhuX.LiR.KangG.KangQ.RaoW.YangM.CaoB.ZhangM.SunY.WangY.ChenX.YuY. and YuQ., CACNA1C polymorphism (rs2283291) is associated with schizophrenia in Chinese males: a case-control study, Disease Markers2019 (2019), 7.
